Skip to main content

Table 1 Clinico-pathological patient characteristics of the gastric cancer validation cohort

From: Interpreting whole genome and exome sequencing data of individual gastric cancer samples

Patient characteristics

Patients

 

[n]

482

Age [years]

 

[mean ± SD]

67.9 ± 11.1

 

median

68

Gender

Men

[n (%)]

297

(61.6)

Women

[n (%)]

185

(38.4)

Follow-up data

Alive

[n (%)]

131

(28.1)

Dead

[n (%)]

335

(71.9)

Localization

Proximal

[n (%)]

149

(30.9)

Distal

[n (%)]

333

(69.1)

pT-category

pT1a

[n (%)]

13

(2.7)

pT1b

[n (%)]

49

(10.2)

pT2

[n (%)]

56

(11.6)

pT3

[n (%)]

190

(39.4)

pT4a

[n (%)]

134

(27.8)

pT4b

[n (%)]

40

(8.3)

pN-category

pN0

[n (%)]

138

(28.8)

pN1

[n (%)]

67

(14.0)

pN2

[n (%)]

85

(17.7)

pN3/a/b

[n (%)]

189

(39.5)

UICC Stage (7th ed.)

IA

[n (%)]

49

(10.4)

IB

[n (%)]

32

(6.8)

IIA

[n (%)]

58

(12.3)

IIB

[n (%)]

47

(9.9)

IIIA

[n (%)]

55

(11.6)

IIIB

[n (%)]

83

(17.5)

IIIC

[n (%)]

66

(14.0)

IV

[n (%)]

83

(17.5)

Stage according to

I

[n (%)]

49

(10.2)

Kiel proposal

II

[n (%)]

84

(17.5)

IIIA

[n (%)]

49

(10.2)

IIIB

[n (%)]

153

(31.9)

IV

[n (%)]

145

(30.2)

Resected lymph nodes

 

[mean ± SD]

19.2 ± 8.2

 

median [n]

18

Positive lymph nodes

 

[mean ± SD]

6.4 ± 7.4

 

median [n]

3

Lymph node ratio (LNR)

 

median [n]

0.2

Tumor grade

G1 / G2

[n (%)]

111

(23.7)

G3 / G4

[n (%)]

357

(76.3)

Resection margin (R-status)

R0

[n (%)]

403

(88.2)

R1/R2

[n (%)]

54

(11.8)